Revision body
2025-06-27
Table 1 by sarcopenia groups
| No Sarcopenia (N=308) |
Sarcopenia (N=157) |
Overall (N=465) |
|
|---|---|---|---|
bias = CKDEPIcradj - mGFRadj | |||
| race_cat | |||
| Asian | 3 (1.0%) | 5 (3.2%) | 8 (1.7%) |
| black | 39 (12.7%) | 15 (9.6%) | 54 (11.6%) |
| mixed | 56 (18.2%) | 15 (9.6%) | 71 (15.3%) |
| white | 210 (68.2%) | 122 (77.7%) | 332 (71.4%) |
| mGFR_cat | |||
| <45 | 13 (4.2%) | 22 (14.0%) | 35 (7.5%) |
| ≥90 | 123 (39.9%) | 30 (19.1%) | 153 (32.9%) |
| 45-59 | 27 (8.8%) | 36 (22.9%) | 63 (13.5%) |
| 60-89 | 145 (47.1%) | 69 (43.9%) | 214 (46.0%) |
Table cisplatin dose by sarcopenia groups
| No Sarcopenia (N=308) |
Sarcopenia (N=157) |
Overall (N=465) |
|
|---|---|---|---|
cisplatin = (egfr > 60) 1 (egfr >= 50) 2 (egfr >= 40) 3 else 5 | |||
| factor(CKDEPIcr21_actualBSA_cisplatin) | |||
| 1 | 286 (92.9%) | 132 (84.1%) | 418 (89.9%) |
| 2 | 8 (2.6%) | 6 (3.8%) | 14 (3.0%) |
| 3 | 9 (2.9%) | 10 (6.4%) | 19 (4.1%) |
| 5 | 5 (1.6%) | 9 (5.7%) | 14 (3.0%) |
| check_CKDEPIcr21_actualBSA_cisplatin | |||
| over_dosed | 27 (8.8%) | 40 (25.5%) | 67 (14.4%) |
| same | 278 (90.3%) | 115 (73.2%) | 393 (84.5%) |
| under_dosed | 3 (1.0%) | 2 (1.3%) | 5 (1.1%) |
| factor(CKDEPIcrcys21_actualBSA_cisplatin) | |||
| 1 | 273 (88.6%) | 112 (71.3%) | 385 (82.8%) |
| 2 | 16 (5.2%) | 19 (12.1%) | 35 (7.5%) |
| 3 | 11 (3.6%) | 13 (8.3%) | 24 (5.2%) |
| 5 | 8 (2.6%) | 13 (8.3%) | 21 (4.5%) |
| check_CKDEPIcrcys21_actualBSA_cisplatin | |||
| over_dosed | 21 (6.8%) | 26 (16.6%) | 47 (10.1%) |
| same | 273 (88.6%) | 120 (76.4%) | 393 (84.5%) |
| under_dosed | 14 (4.5%) | 11 (7.0%) | 25 (5.4%) |
Table within 30 days only
| No (N=127) |
Yes (N=338) |
Overall (N=465) |
|
|---|---|---|---|
bias = CKDEPIcradj - mGFRadj | |||
| bias | |||
| Mean (SD) | -8.96 (13.1) | -12.1 (15.0) | -11.2 (14.6) |
| Median [Q1,Q3] | -10.1 [-16.3,0.695] | -12.0 [-21.9,-2.25] | -11.5 [-20.7,-0.970] |
##
## Wilcoxon rank sum test with continuity correction
##
## data: bias by within_30
## W = 24238, p-value = 0.03164
## alternative hypothesis: true location shift is not equal to 0Table within_30 by sarcopenia groups
| <30 days No Sarcopenia (N=227) |
<30 days Sarcopenia (N=111) |
>=30 days No Sarcopenia (N=81) |
>=30 days Sarcopenia (N=46) |
Overall (N=465) |
|
|---|---|---|---|---|---|
bias = CKDEPIcradj - mGFRadj | |||||
| bias | |||||
| Mean (SD) | -9.25 (14.4) | -17.9 (14.7) | -6.57 (13.2) | -13.2 (11.9) | -11.2 (14.6) |
| Median [Q1,Q3] | -9.07 [-18.9,0.330] | -17.6 [-26.7,-7.00] | -5.58 [-14.8,2.62] | -13.2 [-18.6,-5.96] | -11.5 [-20.7,-0.970] |
Bland-Altman Plot 1 mGFRadj - CKDEPIcr21
Bland-Altman Plot 2 mGFRadj - CKDEPIcysad
Bland-Altman Plot 3 mGFRadj - CKDEPIcrcys21
Bland-Altman Plot 4 mGFRadj - CKDEPIcrb2madj
Bland-Altman Plot 5 mGFRadj - CKDEPIcysb2mbtpadj
Bland-Altman Plot 6 mGFRadj - CKDEPI4mark
